Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
about
A comparison of the effect of nitroparacetamol and paracetamol on liver injuryTetrahydrobiopterin in cardiovascular health and disease.Hemodynamic and cardiovascular effects of nitric oxide modulation in the therapy of septic shock.Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat.Host response modulation in the management of periodontal diseases.CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.Drugs modulating the biological effects of peroxynitrite and related nitrogen species.Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.Peroxynitrite inhibition of Coxsackievirus infection by prevention of viral RNA entry.Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage.The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock.Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet beta cells.Protective effects of isohelenin, an inhibitor of nuclear factor kappaB, in endotoxic shock in rats.Inhibition of nitric oxide restores surfactant gene expression following nickel-induced acute lung injury.Inhibition of experimental gingivitis in beagle dogs with topical mercaptoalkylguanidines.
P2860
Q28345793-0CF09F12-3E86-4B4E-A843-1AB5A4A23AF7Q33687812-525286B8-A652-40D0-9C62-876E61045C68Q34061796-B76C2D9A-57E0-4721-80DB-C2F66A4099A2Q35028480-193BC979-B8E1-4182-9713-1F191D4E6FCEQ36243407-6DF0456C-8FEE-4AB7-B4DD-D9783879B831Q36399304-54B22EC5-D24C-40BF-808F-2F550409F38AQ36496892-209345C2-8A8F-4158-9F7D-DCA31804E122Q37370840-2154F909-528C-442E-84A2-B793D12E1EB8Q37415856-2D3D0E1E-1263-48EF-8280-FDCAECBBE95EQ41116781-7A7ED2FC-2810-4717-BA16-4DA9B8FBB887Q41130911-D7A0B033-9B19-48F9-8EC2-AA2FAC20C5DAQ42545404-3CE5F545-F344-458A-A6DD-766D0490C01BQ43821776-9011ED37-312A-4627-B493-005B572074F5Q44005028-5C41472F-E254-497B-9FC6-937BE51A86B7Q44286294-D0080C8C-A101-4824-9826-F45AEF16FCD5Q46972173-A9F4FB63-D268-4E99-BE2C-93549E0F3C8D
P2860
Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Pharmacological characterizati ...... towards the inducible isoform.
@ast
Pharmacological characterizati ...... towards the inducible isoform.
@en
type
label
Pharmacological characterizati ...... towards the inducible isoform.
@ast
Pharmacological characterizati ...... towards the inducible isoform.
@en
prefLabel
Pharmacological characterizati ...... towards the inducible isoform.
@ast
Pharmacological characterizati ...... towards the inducible isoform.
@en
P2093
P2860
P1476
Pharmacological characterizati ...... towards the inducible isoform.
@en
P2093
A L Salzman
B Zingarelli
G J Southan
T C Gahman
P2860
P304
P356
10.1111/J.1476-5381.1996.TB15589.X
P407
P577
1996-08-01T00:00:00Z